In 2010, it is estimated that 207,090 women will be diagnosed with and 39,840 women will die of breast cancer.1 The lifetime risk for breast cancer in a woman born today is 12.15%. As a result of earlier diagnosis, aggressive resection, and improvements in adjuvant treatment, most women with breast cancer tend to have extended survival relative to patients with other types of cancer. In fact, the 5-year survival for patients with breast cancer is 89%. Currently, more than 2.5 million women in the US have a history of breast cancer.
ChangELWefelJSHessKRAllenPKLangFFKornguthDG: Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol10:1037–442009
KondziolkaDKanoHHarrisonGLYangHCLiewDNNiranjanA: Stereotactic radiosurgery as primary and salvage treatment for brain metastases from breast cancer. J Neurosurg[epub ahead of print October 1 2010; DOI: 10.3171/2010.8.JNS10461]
SerizawaTHiraiTNaganoOHiguchiYMatsudaSOnoJ: Gamma knife surgery for 1–10 brain metastases without prophylactic whole-brain radiation therapy: analysis of cases meeting the Japanese prospective multi-institute study (JLGK0901) inclusion criteria. J Neurooncol98:163–1672010
LinskeyMEAndrewsDWAsherALBurriSHKondziolkaDRobinsonPD: The role of stereotactic radiosurgery in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol96:45–682010. (Erratum published in J Neurooncol 96:69–70)